SYPRINE Drug Patent Profile
✉ Email this page to a colleague
When do Syprine patents expire, and when can generic versions of Syprine launch?
Syprine is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in SYPRINE is trientine hydrochloride. There are ten drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the trientine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Syprine
A generic version of SYPRINE was approved as trientine hydrochloride by WATSON LABS TEVA on February 7th, 2018.
Summary for SYPRINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 150 |
Clinical Trials: | 3 |
Patent Applications: | 3,517 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for SYPRINE |
What excipients (inactive ingredients) are in SYPRINE? | SYPRINE excipients list |
DailyMed Link: | SYPRINE at DailyMed |
Recent Clinical Trials for SYPRINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of British Columbia | N/A |
Yale University | N/A |
Valeant Pharmaceuticals International, Inc. | N/A |
Pharmacology for SYPRINE
Drug Class | Metal Chelator |
Mechanism of Action | Metal Chelating Activity |
Anatomical Therapeutic Chemical (ATC) Classes for SYPRINE
US Patents and Regulatory Information for SYPRINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | SYPRINE | trientine hydrochloride | CAPSULE;ORAL | 019194-001 | Nov 8, 1985 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |